Bing-jun Shi
Chongqing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Dupilumab for Lichen Amyloidosis in an Elderly Multimorbid Patient.
Journal: American journal of therapeutics
Published: July 06, 2026
Abrocitinib as a Novel Therapeutic Option for Elastolytic Giant Cell Granuloma: A Case Report.
Journal: American journal of therapeutics
Published: July 06, 2026
Adjunctive Tofacitinib in Moderate-To-Severe Bullous Pemphigoid: A Single-Center Prospective Cohort Study.
Journal: American journal of therapeutics
Published: June 16, 2026
Abrocitinib for Erythema Multiforme-like Drug Eruptions.
Journal: American journal of therapeutics
Published: June 15, 2026
Tislelizumab-Associated Bullous Pemphigoid.
Journal: American journal of therapeutics
Published: March 23, 2026
Tislelizumab-Associated Toxic Epidermal Necrolysis.
Journal: American journal of therapeutics
Published: March 02, 2026
Tofacitinib in Pigmented Purpuric Dermatoses.
Journal: American journal of therapeutics
Published: February 27, 2026
Envafolimab-Associated Toxic Epidermal Necrolysis.
Journal: American journal of therapeutics
Published: February 11, 2026
Effective Treatment of Darier Disease With Abrocitinib Combined and Acitretin Capsules: A Case Report.
Journal: American journal of therapeutics
Published: January 08, 2026
Sintilimab-Associated Vitiligo.
Journal: American journal of therapeutics
Published: December 17, 2025
Oral JAK Inhibitors in Adolescent Vitiligo: A Real-World Retrospective Study on Treatment Response and Recurrence.
Journal: Journal of the American Academy of Dermatology
Published: December 04, 2025
Last Updated: 09/26/2026